Editor-in-Chief of Special Issue on Integrative Oncology

Editor-in-Chief of Special Issue on Integrative Oncology

Executive Dean of Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine; Chief Professor of Integrative Medicine, Shanghai University of Traditional Chinese Medicine; Director of Medical Oncology Department and Cancer Institute, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine.

Prof. Li had oncology research experience at Cornell University and University of South Florida in the United States. Now he is mainly engaged in researches on molecular mechanism of cancer metastasis and new targets for cancer prevention and treatment, as well as Traditional Chinese Medicine therapies for the clinical prevention and treatment.

He received Special Government Allowances of the State Council and won honorary titles including Millions of Leading Engineering Talent, National Young and Middle-aged Expert with Outstanding Contributions, Shanghai Extraordinary Academic Leader, Shanghai Leading Talent, Shanghai Medical Leading Talent, and Shanghai Traditional Chinese Medicine Leading talents.

He is the president of Specialty Committee of Precision oncology in WFCMS (World Federation of Chinese Medicine Societies) , the vice chairman of Integrated Traditional and Western Medicine Cancer Branch of China Anti-Cancer Association, the vice president of WFCMS Specialty Committee of Classical Traditional Chinese Medicine Formula for Cancer Treatment and Research, and the vice president of Immunology Branch of China Association for the promotion of traditional Chinese Medicine, Vice Chairman of Shanghai Anti-Cancer Association, Deputy Director of Tumor Branch of Shanghai Association of Chinese Integrative Medicine, and Standing Committee Member of Cancer Branch of China Association of Chinese Medicine.

Prof. Li has undertaken 1 national key discipline of traditional Chinese medicine, and presided over 6 major research projects including international ones and others funded by National Natural Science Foundation of China, and 36 major projects at the provincial and ministerial level. The research achievements won 15 awards including Ministry of Education Science and Technology Progress Award, China Medical Science and Technology Award, China Traditional Chinese Medicine Science and Technology Progress Award, and Shanghai Science and Technology Progress Award. He has over 20 national patents and received awards including the first Contribution Awards for China Integrated Traditional Chinese and Western Medicine, Meiji Life Science Award, Shanghai Silver Snake Award, and Shanghai Science and Technology Innovation Model.

He published 5 monographs as an editor-in-chief and more than 360 articles in domestic and foreign journals including, 95 of which were published by SCI journals. The total impact factor is over 300, with the highest of 22.415. Besides, he trained 52 students including masters, doctoral, and postdoctoral researchers.

Main research direction:

1. To prevent and treat precancerous lesions, multi-drug resistance, angiogenesis and metastasis via Integrative Chinese Medicine and Western medicine;

2. Biological basis and mechanism of intestinal microbiota in colorectal cancer with damp-heat syndrome;

3. Establishment of the targeted drug delivery system of Traditional Chinese Medicine and its application in tumor treatment.

Qi Li

Ph.D., M.D., Professor, Chief Physician, Doctoral Advisor, Postdoctoral researcher co-supervisor.